Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine, June 2022.
This is the 8th case of SARS-CoV2 vaccine-induced Sweet's syndrome (3 Pfizer, 2 AstraZeneca, 1 Moderna, 1 Janssen, 1 Sinovac-CoronaVac).
"A 65-year-old woman presented with febrile acute skin eruption (that) developed eight hours after the first dose of the CoronaVac vaccine (Sinovac Life Sciences, Beijing, China). The patient had no history of SARS-CoV-2 infection. She denied any recent drug exposure, or a weight loss or previous similar eruption. Physical examination revealed fever at 39°C associated with well demarcated, oval, tender plaques on the hands and feet."
Free PDF available. onlinelibrary.wiley.com/doi...
